Moderna, Inc. (MRNA)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
154.81+6.43 (+4.33%)
At close: 4:00PM EST
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Performance Outlook
| Previous Close | 148.38 |
| Open | 157.98 |
| Bid | 153.25 x 800 |
| Ask | 153.30 x 1000 |
| Day's Range | 150.88 - 159.60 |
| 52 Week Range | 19.31 - 189.26 |
| Volume | 13,445,205 |
| Avg. Volume | 22,971,459 |
| Market Cap | 61.26B |
| Beta (5Y Monthly) | 1.50 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.96 |
| Earnings Date | May 05, 2021 - May 10, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 160.38 |
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
- Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover
- Weekly Stock List
- Editor's PickYahoo Finance
J&J single-dose COVID-19 vaccine recommended for emergency use
J&J's vaccine recommended for emergency use authorization by independent experts. FDA will make a decision this weekend.Johnson & Johnson's (JNJ) single-dose COVID-19 vaccine is one step closer to emergency use authorization (EAU) after an independent panel voted Friday to recommend the U.S. Food and Drug Administration (FDA) issue the EUA.
- Barrons.com
The Pandemic Tested Healthcare R&D. Now the Future Looks Bright.
Mass vaccinations are necessary to keep Covid-19 at bay. But there’s a lot more than just vaccines in pharma and biotech pipelines.
- Barrons.com
FDA Committee Votes in Favor Of Johnson & Johnson’s Covid-19 Vaccine
Regulator could approve It as soon as Saturday, joining authorized vaccines from Pfizer and Moderna.
© 2021 Verizon Media. All rights reserved.
